Order Article Reprints

Vannas C, Andersson L, Dolatabadi S, Ranji P, Lindén M, Jonasson E, Ståhlberg A, Fagman H, Åman P. Different HSP90 Inhibitors Exert Divergent Effect on Myxoid Liposarcoma In Vitro and In Vivo. Biomedicines. 2022; 10(3):624. https://doi.org/10.3390/biomedicines10030624

Vannas, Christoffer, Lisa Andersson, Soheila Dolatabadi, Parmida Ranji, Malin Lindén, Emma Jonasson, Anders Ståhlberg, Henrik Fagman, and Pierre Åman. 2022. "Different HSP90 Inhibitors Exert Divergent Effect on Myxoid Liposarcoma In Vitro and In Vivo" Biomedicines 10, no. 3: 624. https://doi.org/10.3390/biomedicines10030624

Vannas, C., Andersson, L., Dolatabadi, S., Ranji, P., Lindén, M., Jonasson, E., Ståhlberg, A., Fagman, H., & Åman, P. (2022). Different HSP90 Inhibitors Exert Divergent Effect on Myxoid Liposarcoma In Vitro and In Vivo. Biomedicines, 10(3), 624. https://doi.org/10.3390/biomedicines10030624